In solid tumors, ErbB2/HER2 overexpression is a well-known driver of breast cancer as well as colon cancer, and EGFR overexpression is commonly observed in lung cancer and head and neck cancers (Blume-Jensen and Hunter, 2001; Baselga, 2006). Here, ERBB2 is linked to breast carcinoma.